All Pharma News
Sirnaomics Announces 2023 Annual Results

Sirnaomics Announces 2023 Annual Results
PR NEWSWIRE
28 Mar 2024
Share Share
Sirnaomics will Present its Innovative Dual-Targeted GalNAc muRNA Programs

Sirnaomics will Present its Innovative Dual-Targeted GalNAc muRNA Programs
PR NEWSWIRE
12 Mar 2024
Share Share
Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction

Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction
PR NEWSWIRE
05 Feb 2024
Share Share
Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707

Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707
PR NEWSWIRE
24 Jan 2024
Share Share
Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer

Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer
PR NEWSWIRE
01 Dec 2023
Share Share
Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction

Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction
PR NEWSWIRE
01 Nov 2023
Share Share
Sirnaomics Announces Successful Ph I Clinical Study of RNAi Therapeutic STP707

Sirnaomics Announces Successful Ph I Clinical Study of RNAi Therapeutic STP707
PR NEWSWIRE
30 Aug 2023
Share Share
Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President
PR NEWSWIRE
27 Jul 2023
Share Share
Sirnaomics advances isSCC candidate into late-stage clinical development

Sirnaomics advances isSCC candidate into late-stage clinical development
PHARMAFILE
20 Jun 2023
Share Share
Sirnaomics gears up for Phase III isSCC trial

Sirnaomics gears up for Phase III isSCC trial
Urt? Fultinavi?i?t? CLINICAL TRIALS ARENA
20 Jun 2023
Share Share